SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wockhardt spurts on reporting over 50% surge in Q3 consolidated net profit

14 Feb 2012 Evaluate

Wockhardt is currently trading at Rs. 460.55, up by 18.10 points or 4.09% from its previous closing of Rs. 442.45 on the BSE.

The scrip opened at Rs. 448.00 and has touched a high and low of Rs. 478.00 and Rs. 448.00 respectively. So far 379192 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 478.00 on 14-Feb-2012 and a 52 week low of Rs. 251.25 on 06-Jan-2012.

Last one week high and low of the scrip stood at Rs. 478.00 and Rs. 417.80 respectively. The current market cap of the company is Rs. 5056.49 crore.

The promoters holding in the company stood at 73.64% while Institutions and Non-Institutions held 7.44% and 18.53% respectively.

Drug firm, Wockhardt’s consolidated net profit rose by 50.21% to Rs 212.81 crore in the third quarter ended December 31, 2011, on the back of strong sales in the US market. The company had posted a net profit of Rs 141.67 crore for the corresponding period last fiscal.

Net sales of the company rose by 27.12% to Rs 1,208.67 crore in the quarter ended December 31, 2011, from Rs 950.80 crore in the same period last fiscal.

On a standalone basis, the company posted a net profit of Rs 116.16 crore for the third quarter, as against Rs 66.66 crore for the same period last financial year.

Wockhardt Share Price

1915.70 -22.70 (-1.17%)
06-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.05
Dr. Reddys Labs. 1368.75
Cipla 1471.25
Zydus Lifesciences 1148.05
Lupin 2492.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: